Enlivex Ltd. SEC filings ENLV
Enlivex Ltd. has 419 filings in SEC EDGAR's recent list, going back to Feb 7, 2014. Its latest annual report, Form 20-F, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 9, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jun 27, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jun 26, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jun 26, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jun 19, 2019 | — |
| SC 13D | Ownership over 5% (active) | May 31, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Mar 23, 2016 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2015 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2014 | — |
| SC 13G | Ownership over 5% (passive) | Aug 11, 2014 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- ENLV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1596812
- Former names
- Enlivex Therapeutics Ltd. (until Feb 10, 2026); Bioblast Pharma Ltd. (until Mar 18, 2019); BIO BLAST PHARMA LTD. (until Sep 12, 2016)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.